Global Insomnia Treatment Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Insomnia Treatment Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.
Insomnia Treatment Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Insomnia Treatment Drugs market is projected to reach US$ 3710.3 million in 2034, increasing from US$ 2921.6 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Insomnia Treatment Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Insomnia Treatment Drugs key companies include F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd and Teva Pharmaceutical Industries Ltd., etc. F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V. are top 3 players and held % share in total in 2022.
Insomnia Treatment Drugs can be divided into Prescription Sleep Aids and Over the Counter (OTC) Sleep Aids, etc. Prescription Sleep Aids is the mainstream product in the market, accounting for % share globally in 2022.
Insomnia Treatment Drugs is widely used in various fields, such as Hospital, Pharmacy and Others,, etc. Hospital provides greatest supports to the Insomnia Treatment Drugs industry development. In 2022, global % share of Insomnia Treatment Drugs went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insomnia Treatment Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Segment by Type
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Hospital
Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insomnia Treatment Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Insomnia Treatment Drugs introduction, etc. Insomnia Treatment Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Insomnia Treatment Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Insomnia Treatment Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Insomnia Treatment Drugs market is projected to reach US$ 3710.3 million in 2034, increasing from US$ 2921.6 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Insomnia Treatment Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Insomnia Treatment Drugs key companies include F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd and Teva Pharmaceutical Industries Ltd., etc. F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V. are top 3 players and held % share in total in 2022.
Insomnia Treatment Drugs can be divided into Prescription Sleep Aids and Over the Counter (OTC) Sleep Aids, etc. Prescription Sleep Aids is the mainstream product in the market, accounting for % share globally in 2022.
Insomnia Treatment Drugs is widely used in various fields, such as Hospital, Pharmacy and Others,, etc. Hospital provides greatest supports to the Insomnia Treatment Drugs industry development. In 2022, global % share of Insomnia Treatment Drugs went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insomnia Treatment Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Segment by Type
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Segment by Application
Hospital
Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insomnia Treatment Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Insomnia Treatment Drugs introduction, etc. Insomnia Treatment Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Insomnia Treatment Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.